title: Differential effect of growth- and differentiation-inducing factors on the release of eicosanoids and phospholipids from ML-1 human myeloblastic leukemia cells.
abstract: In the absence of serum, growth of ML-1 human myeloblastic leukemia cells is induced by the insulin-like growth factor-1 (IGF1) together with transferrin (Tf), whereas monocytic differentiation is initiated by the transforming growth factor-beta (TGF-beta) in combination with Tf. Initiation of growth was followed by the rapid release of arachidonic acid (AA), hydroxyeicosatetraenoic acids (HETEs) and phospholipids into the culture medium. In contrast, induction of differentiation occurred without the release of these lipids beyond the level present in control. Inhibitors of enzymes involved in the formation of AA and of HETEs, including phospholipase A2 and lipoxygenases, caused interference with growth but not with differentiation, and an inhibitor of the cyclooxygenase path affected neither growth nor differentiation. These results indicate that the initiation of ML-1 cell growth but not of cell differentiation is dependent upon the increased formation of AA and its derivatives formed primarily via the lipoxygenase path.
authors.affiliation: Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263-0001.
authors.forename: H
authors.initials: H
authors.lastname: Wikiel
authors.forename: L
authors.initials: L
authors.lastname: Zhao
authors.forename: T
authors.initials: T
authors.lastname: Gessner
authors.forename: A
authors.initials: A
authors.lastname: Bloch
mesh_terms: D016718:Arachidonic Acid / Q000378:metabolism; D002109:Caffeic Acids / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D015777:Eicosanoids / Q000378:metabolism*; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000378:metabolism; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology*; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism*; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology; D009637:Masoprocol / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism*; D014168:Transferrin / Q000494:pharmacology*; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D014316:Tritium; D014407:Tumor Cells, Cultured
chemical_list: D002109:Caffeic Acids; D015777:Eicosanoids; D006893:Hydroxyeicosatetraenoic Acids; D016859:Lipoxygenase Inhibitors; D010743:Phospholipids; D014168:Transferrin; D016212:Transforming Growth Factor beta; D014316:Tritium; D016718:Arachidonic Acid; D007334:Insulin-Like Growth Factor I; D009637:Masoprocol; C040048:caffeic acid